H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $67 billion of capital under management, is pleased to announce the sale of its portfolio company, Soleo Health ("Soleo" or ...

Vizient forecasts a 3.84% rise in pharmacy spending for health systems and ambulatory surgery centers, driven by specialty and personalized medicines.

Achondroplasia, which affects around one in 20,000 babies, has just one approved treatment: BioMarin’s Voxzogo. However, new ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window An investigational induced pluripotent stem cell-derived CAR natural killer cell therapy was well tolerated both as ...

The analysis found that trial participants who received retatrutide (Eli Lilly) — an investigational triple agonist that activates the glucose-dependent insulinotropic polypeptide, glucagon-like ...